Apart from its protective effect against multiple organ injuries, BPC157 has also demonstrated cytoprotective (Sikiric et al., 2018) and anti-inflammatory properties and plays a role in maintaining epithelial integrity (Mota et al., 2018)
Neither BPC-157 nor TB-500 is FDA approved for any indication
Incorrect Dose Calculation: Before you do anything, you must understand the math
Some researchers have conceptually explored combining both strategies for potentially synergistic effects on intracellular NAD+ levels, though no published data exists for this specific combination
Recommended daily intake for adults in the UK is 1.5 micrograms, easily achieved through a balanced diet including meat, fish, dairy products, and fortified foods
Potential Benefits Investigated for gastrointestinal mucosal healing: promoting repair of damaged gut lining in inflammatory bowel conditions, ulcers, and leaky gut Gastric acid stability: uniquely suited for oral delivery among therapeutic peptides because BPC-157 is a native component of gastric juice and resists acid degradation VEGF-mediated angiogenesis: promoting mucosal blood vessel formation essential for tissue repair in chronically inflamed or damaged gut tissue Investigated for inflammatory bowel disease (IBD): preclinical evidence for mucosal protection and anti-inflammatory effects in colitis models Gastroparesis support: pro-motility effects via vagal cholinergic pathways investigated in preclinical models of delayed gastric emptying Leaky gut (intestinal hyperpermeability): tight junction protein support and mucosal integrity restoration investigated in preclinical research Oral route delivers medication directly to the gut mucosa where it is most needed, without requiring injection Convenient capsule administration for daily GI protocols, suitable for patients who cannot or prefer not to self-inject Systemic tissue repair support via potential mucosal absorption at therapeutic doses (extent of systemic absorption is under investigation) May complement injectable BPC-157 protocols for patients with both GI and systemic recovery goals Speak with a physician Interested in BPC-157 (Oral)
